Related Experiment Videos
Anticancer drug discovery and development throughout the world
G Schwartsmann1, M J Ratain, G M Cragg
1South-American Office for Anticancer Drug Development, Lutheran University of Brazil, and Postgraduate Course in Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. gschwart.ez@terra.com.br
Summary
This symposium highlighted global anticancer drug discovery and development, emphasizing international collaboration, pharmacogenetics, and harmonizing clinical trial data exchange. Key regions and regulatory bodies discussed efforts to advance new cancer therapies worldwide.
Area of Science:
- Oncology
- Pharmacology
- Drug Development
Background:
- The American Society of Clinical Oncology International Symposium convened to discuss global anticancer drug discovery and development.
- Discussions covered international collaboration, pharmacogenetics, and regulatory aspects of clinical trials.
Purpose of the Study:
- To provide an overview of current global efforts in anticancer drug discovery and development.
- To highlight the importance of international collaboration and regulatory harmonization in advancing cancer therapies.
Main Methods:
- Symposium presentations and panel discussions.
- Overview of international drug development consortia and national contributions (Japan).
- Analysis of logistics and regulatory frameworks for clinical trials in Europe, North America, and Japan.
Main Results:
- Emphasis on promoting international collaboration in natural product-derived anticancer drug discovery.
- Recognition of interethnic differences and pharmacogenetics in drug development.
- Presentation of activities by the Singapore-Hong Kong-Australia Drug Development Consortium.
- Discussion on harmonizing clinical data exchange with input from regulatory agencies (US FDA, Japan's MMEC).
Conclusions:
- International collaboration is crucial for advancing anticancer drug discovery and development.
- Understanding interethnic differences and pharmacogenetics is vital for effective drug development.
- Harmonizing regulatory processes and clinical data exchange facilitates global access to novel cancer therapies.